Digest Network Come funziona
Network
/
Società
Ch
Non verificato

Chiesi Global Rare Diseases

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina Salute BenessereSalute

8 comunicati stampa

Guarda tutti i comunicati
04/06/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
Fonte
Chiesi Global Rare Diseases
Emittente
GLOBENEWSWIRE
1.00
0
02/06/2026
Biotecnologia
Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders
Fonte
Chiesi Global Rare Diseases
Emittente
GLOBENEWSWIRE
1.00
0
30/03/2026
Biotecnologia
Annunci Economici
Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
Fonte
Chiesi Global Rare Diseases
Emittente
GLOBENEWSWIRE
1.00
0
30/01/2026
Biotecnologia
Medicina Salute Benessere
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Fonte
Chiesi Global Rare Diseases
Emittente
GLOBENEWSWIRE
1.00
0
30/01/2026
Biotecnologia
Medicina Salute Benessere
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Fonte
Chiesi Global Rare Diseases
Emittente
GLOBENEWSWIRE
1.00
0
19/06/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Industria
Chiesi Global Rare Diseases assegna finanziamenti per la ricerca per promuovere l'innovazione nelle malattie lisosomiali
Fonte
Chiesi Global Rare Diseases
Emittente
Business Wire
1.00
0
19/06/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Industria
Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases
Fonte
Chiesi Global Rare Diseases
Emittente
Business Wire
1.00
0
Press Release cover image
09/09/2024
Farmaceutica
Sanità
Economia
Start-up
Biologia
Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders
Fonte
Chiesi Global Rare Diseases
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0